Felbatol (Page 7 of 7)

Package Label — Principal Display Panel – 100-count Bottle, 400 mg Tablet

NDC 0037-0430-01
100 Tablets
Felbatol®
(felbamate)
Tablets 400 mg
Rx Only
MEDA
Meda Pharmaceuticals®
Somerset, New Jersey 08873-4120
Usual Dosage: For full prescribing
information, see accompanying
package insert.
Store at controlled room temperature
20°-25°C (68°-77°F).
Dispense the accompanying
Medication Guide to each patient.
Dispense in a tight container.

Manufactured for:
Meda Pharmaceuticals Inc.
Somerset, New Jersey 08873-4120

LB-024G5-10 Rev. 5/2018400934-01

Felbatol Tablets 400 mg Bottle Label
(click image for full-size original)

Package Label — Principal Display Panel – 100-count Bottle, 600 mg Tablet

NDC 0037-0431-01
100 Tablets
Felbatol®
(felbamate)
Tablets 600 mg
Rx Only
MEDA
Meda Pharmaceuticals®
Somerset, New Jersey 08873-4120

Usual Dosage: For full prescribing information,
see accompanying package insert.
Store at controlled room temperature 20°-25°C
(68°-77°F).
Dispense the accompanying Medication
Guide to each patient.
Dispense in a tight container.

Manufactured for:
Meda Pharmaceuticals Inc.
Somerset, New Jersey 08873-4120

LB-024H5-10 Rev. 5/2018
400935-01

Felbatol Tablets 600 mg Bottle Label
(click image for full-size original)

Package Label — Principal Display Panel – 8 fl oz (237 mL) Bottle, 600 mg Suspension

NDC 0037-0442-67
8 fl oz (237 mL)
Felbatol®
(felbamate)
Oral Suspension
Each 5 mL contains
600 mg felbamate
Rx Only
SHAKE WELL
MEDA
PHARMACEUTICALS®
LB-024F5-12 141232-0821
Usual Dosage: For full prescribing information, see
accompanying package insert.
Store at controlled room temperature 20°-25°C (68°-77°F).
Dispense the accompanying Medication Guide to each
patient.
Dispense in a tight container.
Manufactured for:
Meda Pharmaceuticals Inc. Somerset, New Jersey 08873-4120

Felbatol Oral Suspension 8 fl oz Label
(click image for full-size original)
FELBATOL felbamate tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0037-0430
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FELBAMATE (FELBAMATE) FELBAMATE 400 mg
Product Characteristics
Color YELLOW Score 2 pieces
Shape OVAL (capsule shaped) Size 16mm
Flavor Imprint Code 0430;FELBATOL;400
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0037-0430-01 100 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020189 07/29/1993
FELBATOL felbamate tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0037-0431
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FELBAMATE (FELBAMATE) FELBAMATE 600 mg
Product Characteristics
Color ORANGE (Peach) Score 2 pieces
Shape OVAL (capsule shaped) Size 19mm
Flavor Imprint Code 0431;FELBATOL;600
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0037-0431-01 100 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020189 07/29/1993
FELBATOL felbamate suspension
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0037-0442
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FELBAMATE (FELBAMATE) FELBAMATE 600 mg in 5 mL
Inactive Ingredients
Ingredient Name Strength
FD&C YELLOW NO. 6
FD&C RED NO. 40
WATER
SILICON DIOXIDE
DIMETHICONE
Product Characteristics
Color ORANGE (Peach) Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0037-0442-67 237 mL in 1 BOTTLE, PLASTIC None
2 NDC:0037-0442-17 946 mL in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020189 07/29/1993
Labeler — Meda Pharmaceuticals (051229602)

Revised: 11/2011 Meda Pharmaceuticals

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.